Reorganization Is Unifying Theme of CDER FY2005 Report
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
CDER highlights the web of organizational changes it has made in response to challenges ranging from drug safety to slow reviews and shrinking pipelines in the Center’s annual fiscal year Report to the Nation, released Aug. 18.